Aug 012024
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Leqselvi | deuruxolitinib | 7/25/2024 | To treat severe alopecia areata | ||
| Kisunla | donanemab-azbt | 7/2/2024 | To treat Alzheimer’s disease |
Sorry, the comment form is closed at this time.